6-Chloro-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridine

Catalog No.: 
ACMOZA294
CAS No.: 
1443283-97-3
Molecular Formula: 
C7H3ClF3N3
Molecular Weight: 
221.57
6-Chloro-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$257.00InquiryInquiry
100mg95%$374.00InquiryInquiry
250mg95%$527.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Chloro-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridine
IUPAC Name6-chloro-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridine
MDL No.MFCD28677245
Molecular FormulaC7H3ClF3N3
Molecular Weight221.57
SMILESFC(C1=C2C(NN=C2)=NC(Cl)=C1)(F)F
InChI KeyADUBVKTWFSPYRL-UHFFFAOYSA-N
Synonym1H-Pyrazolo[3,4-b]pyridine, 6-chloro-4-(trifluoromethyl)-
CAS No.1443283-97-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACMOZA294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMOZA294 route product structure diagram
    ACMOZA2941443283-97-3
Inquiry

2. ACMOZA294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMOZA294 route product structure diagram
    ACMOZA2941443283-97-3
Inquiry

3. ACMOZA294 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMOZA294 route product structure diagram
    ACMOZA2941443283-97-3
Inquiry

Comments (0)